In the latest edition of Don’t Miss a Beat, Drs. Greene and Vaduganathan are joined by special guest Brendon Neuen, MBBS, MSc, of the George Institute of Global Health. A trialist currently contributing to the FIND-CKD trial, Neuen takes Vaduganathan and Greene on a deep dive into the use of GFR slope as an end point in clinical trials and as a tool in clinical practice.
According to the most comprehensive assessment of worldwide contraceptive use, vast differences in the types of contraceptives that are utilized across regions and age groups were identified.
During follow-up, 2.6% of the patients were diagnosed with depression, while 32.1% were treated with antidepressants.
There was a positive correlation between parental burnout, emotional schemas, and insomnia or hypersomnia.
The worldwide burden of vision loss continues to climb, but there may be solutions with regards to better access to care and improved screening.
Participants defined their acne/acne scars as an “intruder and unwanted companion” in the The Letter to my Disease personification exercise.
The relationship between hours of electronic device use and psychological distress was not mediated by insomnia.
According to a new report from the CDC, as fatal drug overdoses increase across the board, the Black and Indigenous communities represent a significantly greater death rates.
Though transgender medicine has existed for over 100 years, physicians like Dr. Jackson Turbeville are still looking for opportunities to make healthcare more accessible and affordable for patients seeking treatment for a variety of dermatologic conditions.
Cannabis sleep aid use was also linked to increased cannabis dependence symptoms among students using cannabis over 1 year, as well as past-2-week binge drinking among students using alcohol and lifetime cigarette use.
A 19 year-old patient presented with an isolated non-traumatic spontaneous epidural hematoma (EDH), an extremely rare consequence of sickle cell disease.
Dr. David Rosmarin details the recent FDA approval of ruxolitinib cream for vitiligo and how the accessibility of the topical therapy could help the roughly one million patients in the US who can't access standard treatment.
The Duke expert reviews key strategies for starting and continuing care with the pivotal glycemic control agent.
This episode of DocTalk features 5 expert retina specialists discussing the top line data from the conference.
ALT fluctuations remained stable for patients with NAFLD throughout disease progression.
Benzodiazepines, eszopiclone, zolpidem, and zopiclone had higher efficacies than melatonin, ramelteon, and zaleplon for insomnia disorder.
Dr. Patrick Flume encourages clinicians to think a little differently when presented with a patient who has a chronic cough without an identifiable cause.
The efficacy of treating insomnia sustained throughout the 24-week postintervention follow-up period for the electroacupuncture treatment group.
Over 60% of patients in the second year of TENAYA and LUCERNE were on 16 week dosing in the faricimab group.
Dipeptidyl peptidase-4 inhibitors have been linked to cases of bullous pemphigoid across Japan, prompting investigators to suggest trying DPP-4i discontinuation followed by supportive care.
Pediatric neurologist and sleep expert Dr. Amy Licis shares available methods to consider when treating a pediatric patient with sleep issues or sleep disorders accompanied by autism or ADHD.
The novel topical skincare treatment Total Eye was effective in treating periorbital wrinkles, dryness, laxity, and dark circles in patients 35-65 years old.
Machine learning algorithms successfully predicted visual and anatomic outcomes and dosing frequency in patients with macular edema secondary to CRVO.
Data show 77% of eyes with DME in the IRIS Registry received only one type of anti-VEGF agent over an average follow-up of 2.3 years.
The NDA was granted Priority Review designation with a PDUFA target action date of November 26, 2022.
With this decision, ruxolitinib cream has become the first treatment approved by the FDA for the repigmentation of skin in vitiligo.
In the study, 77% of patients treated with the Cal/BD foam treatment were satisfied with its effectiveness, 60% were satisfied with its ease of use, and 73.9% were satisfied in terms of global satisfaction.
Dr. Cohen speaks on combining sun protective measures, such as sunscreen, protective clothing, and antioxidant supplements.
Dr. Lal speaks to how different cultures and different geographical locations can influence UV protection methods, and how sunless tanners can be used to avoid overexposure to UV light outdoors or in tanning beds.
Dr. Craiglow speaks on the public perception of UV safety, how people can best avoid sunburn, and her own personal experience with melanoma and non-melanoma skin cancers.
